Continuous, Real-Time Monitoring of Cocaine in Undiluted Blood Serum via a Microfluidic, Electrochemical Aptamer-Based Sensor

The development of a biosensor system capable of continuous, real-time measurement of small-molecule analytes directly in complex, unprocessed aqueous samples has been a significant challenge, and successful implementation has been achieved for only a limited number of targets. Toward a general solu...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Chemical Society Vol. 131; no. 12; pp. 4262 - 4266
Main Authors Swensen, James S, Xiao, Yi, Ferguson, Brian S, Lubin, Arica A, Lai, Rebecca Y, Heeger, Alan J, Plaxco, Kevin W, Soh, H. Tom
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 01.04.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The development of a biosensor system capable of continuous, real-time measurement of small-molecule analytes directly in complex, unprocessed aqueous samples has been a significant challenge, and successful implementation has been achieved for only a limited number of targets. Toward a general solution to this problem, we report here the Microfluidic Electrochemical Aptamer-based Sensor (MECAS) chip wherein we integrate target-specific DNA aptamers that fold, and thus generate an electrochemical signal, in response to the analyte with a microfluidic detection system. As a model, we demonstrate the continuous, real-time (∼1 min time resolution) detection of the small-molecule drug cocaine at near physiological, low micromolar concentrations directly in undiluted, otherwise unmodified blood serum. We believe our approach of integrating folding-based electrochemical sensors with miniaturized detection systems may lay the groundwork for the real-time, point-of-care detection of a wide variety of molecular targets.
ISSN:0002-7863
1520-5126
DOI:10.1021/ja806531z